Today: 10 June 2026
Browse Category

NASDAQ:BBIO 5 January 2026 - 16 January 2026

BridgeBio Pharma (BBIO) stock edges up after $550 million convertible notes pricing — what investors watch next

BridgeBio Pharma (BBIO) stock edges up after $550 million convertible notes pricing — what investors watch next

BridgeBio Pharma shares rose 0.5% to $76.66 Friday after announcing a $550 million convertible notes sale with a 0.75% interest rate and a $110.58 conversion price. The company expects $538.4 million in net proceeds and plans to use funds to repay 2027 notes and for general purposes. Trading volume reached about 5.9 million shares. The sale is set to close January 21.
16 January 2026
·

Stock Market Today

  • FTSE 100 Edges Higher Despite WH Smith Profit Warning and Geopolitical Tensions
    June 10, 2026, 12:52 PM EDT. The FTSE 100 rose 0.3% to 10,254.81 on Wednesday, outperforming US and European counterparts amid Middle East tensions and rising US inflation. The FTSE 250 gained 0.5% while the AIM All-Share fell 1.1%. US inflation hit a three-year high at 4.2% year-on-year in May, driven by soaring energy prices, according to the US Bureau of Labor Statistics. Core inflation, excluding food and energy, rose 2.9%. Despite the positive UK market performance, WH Smith shares were hit by a profit warning, impacting sentiment. The Bank of Canada kept interest rates at 2.25%, balancing inflation concerns with slower growth. Market caution persists following US military actions against Iran and ongoing geopolitical risks.

Latest articles

Cracker Barrel Jumps After Surprise Profit Forces Investors to Rethink Turnaround

Cracker Barrel Jumps After Surprise Profit Forces Investors to Rethink Turnaround

10 June 2026
Cracker Barrel shares soared 26% after a surprise Q3 profit and raised 2026 revenue and adjusted EBITDA outlook, even as restaurant traffic stayed negative; investors focused on improved guidance and cost cuts, with Wells Fargo upgrading the stock and raising its price target to $50, but risks remain if guest counts don’t recover.
Lemonade Shares Jump as Investors Zero In on Profit Path

Lemonade Shares Jump as Investors Zero In on Profit Path

10 June 2026
Lemonade shares jumped 10.6% to an intraday high above $60 after CEO Daniel Schreiber and CFO Tim Bixby appeared at Morgan Stanley’s U.S. Financials Conference, as investors focused on the company’s reiterated target for positive adjusted EBITDA in Q4 and a fresh TD Cowen price target hike, with shrinking losses and improved underwriting driving optimism.
Go toTop